Related Experiment Video
Updated: Aug 8, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
CD32 expression and signaling is down-regulated by transforming growth factor-beta 1 on human monocytes
T J Reterink1, N Klar-Mohamad, P H Nibbering
1Department of Nephrology, Leiden University Hospital, The Netherlands.
Insights
Transforming growth factor-beta 1 (TGF-β1) reduces CD32 receptor expression and function on monocytes. This immunosuppressive cytokine impacts immune cell signaling by down-regulating CD32 on human cells.
Area of Science:
- Immunology
- Cell Biology
Background:
- CD32 (Fc gamma RII) is a key IgG Fc receptor found abundantly on human immune cells.
- Monocytes play crucial roles in immune responses and are targets for immunomodulatory agents.
Purpose of the Study:
- To investigate the impact of transforming growth factor-beta 1 (TGF-β1) on CD32 expression and function.
- To analyze TGF-β1's effects on primary human monocytes and monocytic cell lines.
Main Methods:
- Treatment of monocytes and monocytic cell lines (U937, THP-1, Mono mac-6) with varying concentrations and durations of TGF-β1.
- Quantification of CD32 expression levels via flow cytometry.
- Analysis of CD32 mRNA levels.
- Assessment of intracellular calcium (Ca2+) flux upon CD32 cross-linking.
Main Results:
- TGF-β1 significantly down-regulates CD32 expression on monocytes and monocytic cell lines in a dose- and time-dependent manner.
- A 54% mean reduction in CD32 expression on THP-1 cells was observed after 24 hours with 1 ng/ml TGF-β1.
- TGF-β1 induced a twofold decrease in CD32 mRNA levels.
- TGF-β1 treatment reduced the downstream signaling, indicated by a 50% decrease in Ca2+ increase upon CD32 cross-linking.
Conclusions:
- TGF-β1 effectively suppresses CD32 expression and function on human monocytes and related cell lines.
- The observed down-regulation affects both protein and mRNA levels of CD32.
- TGF-β1 diminishes CD32-mediated downstream signaling, contributing to its immunosuppressive effects.
Abstract:
CD32 (Fc gamma RII) is the most abundantly distributed class of IgG Fc receptors in the human body. In this study, we analyzed the effect of transforming growth factor (TGF)-beta 1, a cytokine with strong immunosuppressive function, on the expression and function of CD32 on freshly isolated peripheral blood monocytes and three human monocytic cell lines, U937, THP-1 and Mono mac-6. We found that TGF-beta 1 down-regulates CD32 expression on monocytes and all monocytic cell lines in a dose- and time-dependent fashion. A mean down-regulation of CD32 expression on THP-1 cells of 54 +/- 3.2% after 24 h was found at a concentration of 1 ng/ml TGF-beta 1. At the mRNA level, TGF-beta 1 induced a twofold down-regulation of CD32. Cross-linking of CD32 induced an increase in the concentration of intracellular Ca2+, which was reduced by 50% by TGF-beta 1, suggesting a decreased downstream signaling mediated by the receptor.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of Hematopoietic Stem Cells
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

